A major focus of the post-graduate courses in Good Manufacturing Practice (GMP) SeerPharma deliver at the University of Technology Sydney (UTS) is skill-building for the real-world.
This post was first published in July 2017 and has been updated to reflect changes.
The Therapeutic Goods Administration (TGA) is part of the Australian Federal Government’s Department of Health and is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods, including medicines
Good Manufacturing...
SeerPharma is assisting a number of start-up biotech companies with implementing a basic Quality Assurance Plan (QAP) – a building block of a fully-fledged Quality Management System. The QAP can be put in place to grow as companies mature.
Kicking off 2017 saw SeerPharma deliver our most popular course “Introduction to GMP” across the Asia-Pacific region.
Asia’s biopharmaceutical industry has evolved from a manufacturing destination to a goto market for clinical development and a hotbed of innovation. Asia contains some of the world’s leading pharma and biopharma markets on the planet.
SeerPharma has commenced work assisting a firm looking to manufacture and supply multivitamin tablets to China and Australia. Our team has been engaged to help obtain a TGA GMP license by ensuring that the manufacturer has a suitable Quality Management System and will alsohelp ensure that the facility and equipment the firm plans on using is...
Pharmacists are expected to be aware of and comply with relevant practice standards and guidelines on compounding. Despite certain exceptions, compounded medicines must meet the quality standards set out in the Therapeutic Goods Act 1989 (Cth).
SeerPharma in partnership with the Life Sciences Industry Group of the SingaporeManufacturing Federation held its annual Symposium for 2017 in Singapore, March 16th to 17th. The event saw over 50 delegates from across the Asia-Pacific region attend. Companies from countries such as The Philippines, Malaysia, Singapore, Australia and Sri Lanka were
There has been, is and always will be a strong focus on data in the pharmaceutical industry. When there is a manufacturing problem, data analysis can often indicate where to look for the root cause but profound process knowledge is usually required to find it.
In this article, we’ll look at 3 scenarios where pharmaceutical processing problems...
PIC/S Authorities are coming to Melbourne in April 2017 and MTPConnect - the medical technology, biotechnology and pharmaceutical (MTP) Industry Growth Centre - is going to connect the Australian sector with PIC/S event participants.
